What Researchers Did
The European Committee for Hyperbaric Medicine developed a position statement outlining guidelines for the safe and effective use of hyperbaric oxygen therapy (HBOT) in critically ill intensive care unit (ICU) patients.
What They Found
They recommended that HBOT for ICU patients should only be considered after a thorough risk/benefit assessment, ensuring it does not delay or interrupt overall patient management. Guidelines also stipulated that hyperbaric facilities must be specifically designed and fully equipped for ICU patients, ideally located near the ICU, and staffed by a well-trained team of physicians, nurses, and technicians.
What This Means for Canadian Patients
Canadian patients requiring hyperbaric oxygen therapy while critically ill would benefit from similar rigorous risk/benefit assessments and specialized facility standards to ensure their safety and continuity of care. Adherence to such guidelines would help ensure that HBOT is integrated seamlessly into their existing intensive care management without compromising monitoring or treatment.
Canadian Relevance
This study is a European position statement and does not have a direct Canadian connection.
Study Limitations
As a position statement, this guideline primarily synthesizes existing knowledge and expert consensus rather than presenting new empirical data or clinical trial results.